• 1
    Ozols RF, Young RC. High-dose cisplatin therapy in ovarian cancer. Semin Oncol 1985; 12 (6 Suppl): 2130.
  • 2
    Kedar A, Cohen ME, Freeman AI. Peripheral neuropathy as a complication of cis-dichlorodiammineplatinum (II) treatment: a case report. Cancer Treat Rep 1978; 62: 81921.
  • 3
    Von Hoff DD, Reichert CM, Cunco R, et al. Demyelination of peripheral nerves associated with cis-diamminedichloroplatinum (II) (DDP) therapy [abstract]. Proc Am Assoc Cancer Res ASCO 1979; 20: 91.
  • 4
    Piehl IJ, Meyer D, Perlia CP, Wolfe VI. Effects of cisdiammine-dichloroplatinum (NSC-119875) on hearing function in man. Cancer Chemother Rep 1974; 58: 8715.
  • 5
    Fleming S, Peppard S, Ratanatharathorn V, Schumacher M, Weaver A, Al-Sarraf, et al. Ototoxicity from cis-platinum in patients with stages III and IV previously untreated squamous cell cancer of the head and neck. Am J Clin Oncol 1985; 8: 3026.
  • 6
    Madias NE, Harrington JT. Platinum nephrotoxicity. Am J Med 1978; 65: 30714.
  • 7
    Leonard BJ, Eccleston E, Jones D, Todd P, Walpole A. Antileukaemic and nephrotoxic properties of platinum compounds. Nature 1971; 234: 435.
  • 8
    Alberts DS, Green S, Hannigan EV, O'Toole R, Stock-Novack D, Anderson P, et al. Improved therapeutic index of carboplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol 1992; 10: 70617.
  • 9
    Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 10315.
  • 10
    Fleming TR, Harrington DP, O'Brien PC. Designs for group sequential tests. Controlled Clin Trials 1984; 5: 34861.
  • 11
    Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 45781.
  • 12
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 16370.
  • 13
    Cox DR. Partial likelihood. Biometrika 1975; 62: 26976.
  • 14
    Cox DR. Regression models and life tables. J Roy Stat Soc [B] 1972; 34: 187220.
  • 15
    Cox DR. The analysis of binary data. London: Methuen, 1970.
  • 16
    Lehmann EL. Nonparametrics: statistical methods based on ranks. San Francisco: Holden-Day, 1975.
  • 17
    Egorin MJ, Van Echo DA, Olman EA, Whitacre MY, Forrest A, Aisner J. Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum (II) analogue diamminecyclobutanedi-carboxylatoplatinum. Cancer Res 1985; 45: 65026.
  • 18
    Calvert AH, Newell DR, Gumbrell LA, O'Reilly S, Burnell M, Boxall FE, et al. Carboplatin dosage: prospective evaluation of a simple formula based on renal function. J Clin Oncol 1989; 7: 174856.